24
Participants
Start Date
January 9, 2024
Primary Completion Date
February 13, 2024
Study Completion Date
June 30, 2024
Piperaquine tablets , which will be administered orally as a single dose of 480mg (320mg+160mg).
The first arm will receive Piperaquine tablets, that will be administered orally. Sub-curative regimen will be given as two tablets of 320mg and 160mg (total of 480mg).
Doxycycline (100mg tablets strength as Doxycycline Hyclate) will also be administered orally and will be given as 1 tablet (100mg) Once daily for 7 days.
The second arm will receive Doxycycline (100mg tablets strength as Doxycycline hyclate) that will also be administered orally. Sub-curative regimen will be given as 1 tablet (100mg) once daily for 7 days.
Ifakara Health Institute, Pwani
University of Oxford
OTHER
Ifakara Health Institute
OTHER